Which Is Your Best Bet On Africa: Old Mutual plc, Hikma Pharmaceuticals Plc Or PZ Cussons plc?

G A Chester puts Africa growth-story bets Old Mutual plc (LON:OML), Hikma Pharmaceuticals Plc (LON:HIK) and PZ Cussons plc (LON:PZC) under the spotlight.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

As the world industrialises, Africa remains the last continent with the greatest latent potential for growth. If you’re interested in tapping into this potential, UK-listed companies Old Mutual (LSE: OML), Hikma Pharmaceuticals (LSE: HIK) and PZ Cussons (LSE: PZC) all have substantial exposure to African markets.

Old Mutual

Established in South Africa in 1845, Old Mutual is an investment, savings, insurance and banking group. The company is a member of the FTSE 100.

In 2014, 68% of Old Mutual’s revenue was earned in Southern Africa, while 25% came from the UK, which is the group’s second-largest market. Within the Southern Africa region, South Africa dominates, but Old Mutual continues to extend its reach beyond its historic homeland, as it seeks to become “an African financial services champion”.

Old Mutual trades on a current-year forward P/E of 11.5, falling to 10.5 next year. With forward earnings growth per annum expected to run at around 10% (and to support strong dividend growth from a starting yield of 4.3%), the shares seem to offer good value.

Hikma Pharmaceuticals

Founded in 1978 by a Palestinian-born former marketing manager of US drugs heavyweight Eli Lilly, Hikma Pharmaceuticals’ growth has been impressive; in fact, so much so that the company has just been promoted to the FTSE 100.

The US is Hikma’s biggest market by revenue (51%), but the company also earns substantial revenue from the Middle East and North Africa (43%). Hikma’s North African markets extend all the way from Morocco across to Egypt, and down the Red Sea to Sudan and Somalia.

Hikma posted 9% revenue and earnings growth for 2015, but analysts are expecting a more subdued 2015, partly because of currency exchange rates. Hikma trades on a forecast P/E of about 23, with a dividend yield of less than 1%. On the face of it, not particularly good value, but the company does have the resources to make earnings-enhancing acquisitions (as it has in the past).

PZ Cussons

The origins of FTSE 250 firm PZ Cussons can be traced back to a trading post set up in Sierra Leone in 1884. The personal care, home care and foods group continues to maintain a strong presence in Africa, centred on Nigeria, Ghana and Kenya. Revenue by geographical region breaks down as: Africa 40%, Europe 34% and Asia 26%.

Investing for African growth is a long-term affair, and recent events in and around Cussons’ biggest single market — Nigeria — highlight the turbulence that can be expected along the way. The Ebola outbreak, disruption by violent Islamist movement Boko Haram and a devaluation of the Naira are all currently impacting on Cussons’ overall group performance.

Analysts are forecasting a modest decline in earnings for the company’s fiscal year ending 31 May. However, they also expect a return to high single-digit/low double-digit growth for the year to May 2016, putting Cussons on a P/E of 18 with a dividend yield of 2.5%. This seems reasonable value against peers in the highly-rated consumer goods sector.

Companies with powerful brands — such as Cussons — are among my personal favourites as buy-and-hold investments. But it occurs to me that Old Mutual (with its strength in Southern Africa), Hikma (with its North African markets) and Cussons (with its focus on West and East Africa) together offer exposure to different growth themes across the continent that could all pay off in the long term.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of PZ Cussons. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »